ALBIO — Biosynex SA Cashflow Statement
0.000.00%
Last trade - 00:00- €14.56m
- €66.87m
- €95.19m
Annual cashflow statement for Biosynex SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 107 | 21.2 | -35.6 | -43.4 | -58.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.031 | -0.008 | -0.017 | 0.565 | -6.66 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.578 | -37.3 | 14.5 | 12.9 | 6.8 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 110 | 4.95 | -9.65 | -10.1 | -5.89 |
| Capital Expenditures | -19 | -37.8 | -39.5 | -4.84 | -2.69 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -9.95 | -9 | -15.3 | 0.244 | 5.73 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -29 | -46.8 | -54.8 | -4.6 | 3.04 |
| Financing Cash Flow Items | -1.78 | -21.2 | 0.808 | 3.29 | -0.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.4 | -10.8 | 5.17 | -0.801 | 6.91 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 95.3 | -52.6 | -59.3 | -15.5 | 3.81 |